Looking for Sentiment Analysis? Discover the most popular stocks on Reddit by using our Sentiment Tracker
Market Cap 241.86M P/E - EPS this Y 26.20% Ern Qtrly Grth -
Income -66.78M Forward P/E -3.96 EPS next Y 10.00% 50D Avg Chg -11.00%
Sales 64.94M PEG - EPS past 5Y - 200D Avg Chg 9.00%
Dividend N/A Price/Book 1.31 EPS next 5Y - 52W High Chg -35.00%
Recommedations 1.80 Quick Ratio 4.03 Shares Outstanding 66.21M 52W Low Chg 123.00%
Insider Own 5.84% ROA -21.40% Shares Float 47.05M Beta 1.04
Inst Own 50.23% ROE -45.56% Shares Shorted/Prior 18.94K/26.81K Price 3.76
Gross Margin 68.30% Profit Margin -102.84% Avg. Volume 65,309 Target Price 6.00
Oper. Margin -94.92% Earnings Date Nov 5 Volume 41,974 Change 3.58%
About SOPHiA GENETICS SA

SOPHiA GENETICS SA operates as a cloud-native software technology company in the healthcare space. The company offers SOPHiA DDM platform, a cloud-native software platform for analyzing data and generating insights from multimodal data sets and diagnostic modalities. Its SOPHiA DDM platform and related solutions, applications, products, and services are used by hospitals, laboratories, and biopharmaceutical companies through its own sales force as well as distributors and industry collaborators in Switzerland, France, Italy, rest of Europe, North America, the United States, Latin America, and the Asia-pacific. SOPHiA GENETICS SA was incorporated in 2011 and is headquartered in Rolle, Switzerland.

SOPHiA GENETICS SA News
05:30 AM SOPHiA GENETICS Launches MSK-IMPACT® powered with SOPHiA DDM™ at AMP 2024
11/08/24 Earnings Release: Here's Why Analysts Cut Their SOPHiA GENETICS SA (NASDAQ:SOPH) Price Target To US$6.00
11/06/24 SOPHiA GENETICS Faces Financial Challenges Amid Losses
11/06/24 SOPHiA GENETICS Third Quarter 2024 Earnings: Misses Expectations
11/06/24 Sophia Genetics SA (SOPH) Q3 2024 Earnings Call Highlights: Navigating Challenges with ...
11/06/24 Q3 2024 Sophia Genetics SA Earnings Call
11/05/24 SOPHiA GENETICS Promotes Ross Muken to President and Appoints George Cardoza as Chief Financial Officer
11/05/24 SOPHiA GENETICS Reports Third Quarter 2024 Results
11/04/24 SOPHiA GENETICS SA (SOPH): A Bull Case Theory
11/01/24 Fulgent Genetics (FLGT) Surges 5.8%: Is This an Indication of Further Gains?
10/28/24 US Penny Stocks To Watch In October 2024
10/22/24 SOPHiA GENETICS to Announce Financial Results for Third Quarter 2024 on November 5, 2024
09/14/24 SOPHiA GENETICS Presents Ground-Breaking Multimodal Research on AI-Driven Patient Stratification at ESMO 2024
09/12/24 SOPHiA GENETICS Announces Poster Presentations at ESMO 2024
09/12/24 SOPHiA GENETICS Announces Updates on SOPHiA UNITY at ESMO 2024
09/11/24 Sophia Genetics and AstraZeneca collaborate to expand liquid biopsy test rollout
09/10/24 SOPHiA GENETICS and AstraZeneca Collaborate to Further Expand Global Access to Liquid Biopsy Testing
09/05/24 SOPHiA GENETICS Announces Validation of Novel Clinical Trial Assay Together with Precision for Medicine at World Clinical Biomarkers & CDx 2024
09/04/24 SOPHiA GENETICS Unveils New Generation of the SOPHiA DDMTM Platform at Morgan Stanley Healthcare Conference 2024
08/28/24 SOPHiA GENETICS to Present at the 22nd Annual Morgan Stanley Healthcare Conference and 9th Annual TD Cowen FutureHealth Conference
SOPH Chatroom

User Image DonCorleone77 Posted - 2 weeks ago

$SOPH Sophia Genetics backs FY24 revenue view $65M-$67M, consensus $65.66M Backs FY24 adjusted gross margin view 72%-72.5%. Camblong added, "Looking ahead, I'm excited by major growth catalysts such as our new Liquid Biopsy application MSK ACCESS(R) powered with SOPHiA DDMTM, which has already attracted an impressive 18 new customers since its launch in Q2. I am also excited by the recent launch of the application's Solid Tumor testing counterpart, MSK-IMPACT(R) powered with SOPHiA DDMTM. These applications, which enable any institution across the globe to launch best-in-class Liquid Biopsy and Solid Tumor testing, are also igniting strong interest from BioPharma companies who can leverage the decentralized, global network to improve deployment and development of their therapies."

User Image DonCorleone77 Posted - 2 weeks ago

$SOPH Sophia Genetics reports Q3 EPS (28c), consensus (23c) Reports Q3 revenue $15.85M, consensus $15.85M. "Record analysis volume drove a reacceleration of Clinical growth across most key geographies in Q3, with volume increasing 16% year-over-year, offset by expected softness in BioPharma," said Jurgi Camblong, CEO and co-founder. "We also delivered another quarter of strong forward-looking indicators with 20 new customer signings, including major wins in the U.S., the U.K., and Brazil. I am proud of our ability to deliver strong new business momentum, while also excelling at cost management. In Q3, we expanded adjusted gross margins to 73.1% and improved cash burn significantly by 39% year-over-year to $9.6 million, while also strengthening commercial teams and customer-facing operations."

User Image Stock_Titan Posted - 2 months ago

$SOPH SOPHiA GENETICS Presents Ground-Breaking Multimodal Research on AI-Driven Patient Stratification at ESMO 2024 https://www.stocktitan.net/news/SOPH/sop-hi-a-genetics-presents-ground-breaking-multimodal-research-on-ai-k695jbrj4qbr.html

User Image Stock_Titan Posted - 2 months ago

$SOPH SOPHiA GENETICS Announces Poster Presentations at ESMO 2024 https://www.stocktitan.net/news/SOPH/sop-hi-a-genetics-announces-poster-presentations-at-esmo-vei5vtwf84r7.html

User Image Stock_Titan Posted - 2 months ago

$SOPH SOPHiA GENETICS Announces Updates on SOPHiA UNITY at ESMO 2024 https://www.stocktitan.net/news/SOPH/sop-hi-a-genetics-announces-updates-on-sop-hi-a-unity-at-esmo-2zc4kz3dd8e4.html

User Image DARKP00L Posted - 2 months ago

$SOPH SOPHiA GENETICS and AstraZeneca Collaborate to Further Expand Global Access to Liquid Biopsy Testing

User Image Stock_Titan Posted - 2 months ago

$SOPH $AZN SOPHiA GENETICS and AstraZeneca Collaborate to Further Expand Global Access to Liquid Biopsy Testing https://www.stocktitan.net/news/SOPH/sop-hi-a-genetics-and-astra-zeneca-collaborate-to-further-expand-aclq0jm40i7p.html

User Image Stock_Titan Posted - 2 months ago

$SOPH SOPHiA GENETICS Announces Validation of Novel Clinical Trial Assay Together with Precision for Medicine at World Clinical Biomarkers & CDx 2024 https://www.stocktitan.net/news/SOPH/sop-hi-a-genetics-announces-validation-of-novel-clinical-trial-assay-ti7nvwg18x19.html

User Image Himel92 Posted - 3 months ago

The Last month Performance for $SOPH Opening Price: $4.60 Closing Price: $3.50 Highest Price: $4.77 Lowest Price: $2.70 Percentage Change: -23.91% Data analyst: AITX

User Image TUZZIE Posted - 3 months ago

$SOPH

User Image MIMI133 Posted - 3 months ago

$SOPH will this ever return to $5?

User Image GPS_hawkeye Posted - 3 months ago

$EDIT gene-editing , $SOPH cloud-medical-tech genetics-related companies missing estimates and price drops $EDIT 52wk low $SOPH drops 10% https://finance.yahoo.com/quote/EDIT

User Image LewisDaKat Posted - 3 months ago

News $SOPH SOPHiA GENETICS Reports Second Quarter 2024 Results https://marketwirenews.com/news-releases/sophia-genetics-reports-second-quarter-2024-results-5614979700662074.html $SOPH

User Image IntraTrades Posted - 3 months ago

$CLNN 42.72% $RCON 42.21% $SOPH 35.33% $EVA 34.72% $SPWR 32.70% •

User Image VrtcIl Posted - 3 months ago

What are your targets on $SOPH? Closest round level at 5. Take out profits right before those round numbers. Many orders on those levels are waiting to get filled. Price: 4.05 Float: 46.8M Short Float: 0.2 % 💰 Dollar Volume: 11.8K ℹ️ Switzerland | Health Information Services

User Image _www_larval_com_ Posted - 3 months ago

$SOPH 4%[-12%] $MKDW -3%[-34%] $STVN -3%[7%] $ELEV 3%[-63%] $ZI 3%[-18%] most notable movement into the final minutes of trading.

User Image _www_larval_com_ Posted - 3 months ago

$SOPH just slipped -10% lower to -24% (~93Kv) a few minutes ago, 08/16 options, follow for more volatility.

User Image VrtcIl Posted - 3 months ago

$SOPH is one to watch for the day and maybe the following days as well if it manages to keep holding up. But never blindly enter and be patient for entry points with a defined risk. Price: 3.76 Float: 46.8M Short Float: 0.2 % 💰 Dollar Volume: 4.1K ℹ️ Switzerland | Health Information Services

User Image Stock_Titan Posted - 3 months ago

$SOPH SOPHiA GENETICS Reports Second Quarter 2024 Results https://www.stocktitan.net/news/SOPH/sop-hi-a-genetics-reports-second-quarter-2024-m7hyanmpuqni.html

User Image Stock_Titan Posted - 07/29/24

$SOPH SOPHiA GENETICS Announces L'hôpital Universitaire Avicenne is Live on SOPHiA DDM™ https://www.stocktitan.net/news/SOPH/sop-hi-a-genetics-announces-l-hopital-universitaire-avicenne-is-live-il05njhl81ji.html

User Image Stock_Titan Posted - 07/24/24

$SOPH SOPHiA GENETICS Announces Expanded Relationship with Canada-Based OncoHelix https://www.stocktitan.net/news/SOPH/sop-hi-a-genetics-announces-expanded-relationship-with-canada-based-ih34a8lprnts.html

User Image Stock_Titan Posted - 07/23/24

$SOPH SOPHiA GENETICS to Announce Financial Results for Second Quarter 2024 on August 6, 2024 https://www.stocktitan.net/news/SOPH/sop-hi-a-genetics-to-announce-financial-results-for-second-quarter-1uh9fx3x8gyp.html

User Image lolord Posted - 07/23/24

$SOPH Powered by $NVDA https://www.sophiagenetics.com/press-releases/sophia-genetics-to-launch-new-whole-genome-sequencing-capabilities/

User Image FlynancialAnalyst Posted - 4 months ago

@Doozio this mkt is $BLTE $SOPH a $KN differently

User Image Stock_Titan Posted - 4 months ago

$SOPH India-Based Dhiti Omics is Now Live on SOPHiA DDM™ https://www.stocktitan.net/news/SOPH/india-based-dhiti-omics-is-now-live-on-sop-hi-a-4xqr7e48nxmq.html

User Image _www_larval_com_ Posted - 4 months ago

$SOPH has reverted 7% higher to 0% (~44Kv) moments ago, follow for more volatility.

User Image erevnon Posted - 06/27/24

Guggenheim initiates coverage on Sophia Genetics $SOPH at Buy rating and a price target of https://marketsblock.com/stock-upgrades-and-downgrades/

User Image BioTuesdays Posted - 06/24/24

SOPHiA GENETICS has announced its new residual acute myeloid (RAM) application, SOPHiA DDM RAM Solution, supporting measurable residual disease (MRD) testing to help monitor cancer and outpace relapse. The new offering will be available to customers worldwide this summer $SOPH https://biotuesdays.com/2024/06/24/sophia-genetics-expands-oncology-portfolio-with-new-ram-application/

User Image Stock_Titan Posted - 06/24/24

$SOPH SOPHiA GENETICS Publishes Results of 2024 Annual General Meeting https://www.stocktitan.net/news/SOPH/sop-hi-a-genetics-publishes-results-of-2024-annual-general-s4p0z6xoxaqs.html

User Image Stock_Titan Posted - 06/24/24

$SOPH SOPHiA GENETICS Launches New Residual Acute Myeloid (RAM) Application https://www.stocktitan.net/news/SOPH/sop-hi-a-genetics-launches-new-residual-acute-myeloid-ram-gf762bvqfbza.html

Analyst Ratings
RBC Capital Outperform Aug 7, 24
Guggenheim Buy Jun 27, 24
BTIG Buy Mar 6, 24
RBC Capital Outperform Mar 6, 24
RBC Capital Outperform Jan 12, 24
RBC Capital Outperform Nov 29, 23
Credit Suisse Neutral May 10, 23
Morgan Stanley Overweight May 10, 23
Morgan Stanley Overweight Mar 8, 23